Versameb
ID: 6246719Versameb is a Basel-based biotechnology company focusing on discovering and developing RNA-based drugs for modulation of protein expression.
4
Funding Rounds
$24.1m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Versameb has raised a total of $24.1m in funding over 4 rounds.
Key Insights:
- Versameb Seed round, July 2020: $6m
- Versameb July 2020 Seed Funding Round: $6.4m
- Versameb Seed C round, October 2019: $6.4m
- Versameb Seed round, December 2018: $5.3m
Industries
Versameb is active in the following industries: